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Although angiotensin II (ANGII) exerts an important
influence on the mean level of renal blood flow (RBF) and
contributes to the fine tuning of glomerular filtration rate,
the contribution of ANGII to the autoregulation of RBF is
believed currently to be negligible (Navar et al. 1996). This
view has been derived from studies in which the
autoregulation of RBF had been assessed by the classical
method of stepwise artificial reductions in renal artery
pressure (RAP) (Abe et al. 1976; Arendshorst & Finn,
1977; Hall et al. 1977; Persson et al. 1988).
However, under physiological conditions, fluctuations in
RAP occur more dynamically and the process of RBF
autoregulation itself exhibits a characteristic dynamic
response pattern (Daniels et al. 1990; Holstein-Rathlou et
al. 1991; Cupples et al. 1996; Just et al. 1998b). Therefore,
several possibilities for a contribution from the
renin–angiotensin system remain, which might have
escaped detection when using the classical stepwise
method. There are at least three possible ways in which
ANGII could play a role in short-term autoregulation of
RBF. First, ANGII might be involved (either directly or by
modulating other mechanisms) in a frequency range that
is faster than the 2–5 min duration of the artificial pressure
steps, similar to the effects of nitric oxide (Just et al. 1999).
Second, the total autoregulatory capacity is used only
partially under physiological conditions (Just et al. 1998b),
and this limited level of regulation might well be modified by
ANGII. Finally, even if the ANGII does not actively
participate in basal autoregulation, it might alter the relative
contribution of those mechanisms that are involved.
At present, RBF autoregulation is thought to be brought
about by the myogenic response and tubuloglomerular
feedback (TGF) (Navar et al. 1996) and perhaps by an
additional slower mechanism (Just et al. 2001), which all
seem to contribute approximately equally to the overall
regulatory effect (Moore et al. 1979; Baker et al. 1981;
Takenaka et al. 1994; Just et al. 2001). There is abundant
evidence that ANGII enhances TGF (Huang & Navar,
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The influence of angiotensin II (ANGII) on the dynamic characteristics of renal blood flow (RBF)
was studied in conscious dogs by testing the response to a step increase in renal artery pressure
(RAP) after a 60 s period of pressure reduction (to 50 mmHg) and by calculating the transfer
function between physiological fluctuations in RAP and RBF. During the RAP reduction, renal
vascular resistance (RVR) decreased and upon rapid restoration of RAP, RVR returned to baseline
with a characteristic time course: within the first 10 s, RVR rose rapidly by 40 % of the initial change
(first response, myogenic response). A second rise began after 20–30 s and reached baseline after an
overshoot at 40 s (second response, tubuloglomerular feedback (TGF)). Between both responses,
RVR rose very slowly (plateau). The transfer function had a low gain below 0.01 Hz (high
autoregulatory efficiency) and two corner frequencies at 0.026 Hz (TGF) and at 0.12 Hz (myogenic
response). Inhibition of angiotensin converting enzyme (ACE) lowered baseline RVR, but not the
minimum RVR at the end of the RAP reduction (autoregulation-independent RVR). Both the first
and second response were reduced, but the normalised level of the plateau (balance between
myogenic response, TGF and possible slower mechanisms) and the transfer gain below 0.01 Hz were
not affected. Infusion of ANGII after ramipril raised baseline RVR above the control condition. The
first and second response and the transfer gain at both corner frequencies were slightly augmented,
but the normalised level of the plateau was not affected. It is concluded that alterations of plasma
ANGII within a physiological range do not modulate the relative contribution of the myogenic
response to the overall short-term autoregulation of RBF. Consequently, it appears that ANGII
augments not only TGF, but also the myogenic response.
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1988; Mitchell & Navar, 1988; Schnermann & Briggs,
1989b; Braam & Koomans, 1995), which appears to play a
role during physiological adaptation, such as after volume
expansion (Schnermann & Briggs, 1990). Accordingly, it is
conceivable that ANGII may alter the relative contribution
of the mechanisms underlying RBF autoregulation by
enhancing the contribution of TGF. Therefore, the aim of
the present study was to investigate the role of ANGII in
the autoregulation of RBF in response to dynamic changes
in RAP. For this purpose, the responses of RBF to rapid
pressure steps, as well as to physiological fluctuations in
RAP, were investigated in conscious dogs in the presence
of normal, reduced and elevated plasma concentrations of
ANGII.
METHODS
Experiments (n = 58) were conducted on 23 conscious foxhounds
(27–37 kg) in accordance with the national guidelines for the care
and use of research animals (Reg. Präs. Karlsruhe license No.
37-9185.81/156/96). The dogs were housed under in an artificial
light–dark cycle (06.00–18.00 h light) and were fed a standard diet
(SSNIFF Spezialdiäten GmbH, Soest, Germany) with free access
to tap water. For more details on the following description of
instrumentation, measurements and data handling, see Just et al.
(1998b, 2001).
Chronic instrumentation
The dogs were prepared surgically under sterile conditions. After
premedication with atropine (0.5 mg s.c., Braun, Melsungen,
Germany) and propionylpromazine (0.5 mg kg_1 s.c., Combelen,
Bayer, Leverkusen, Germany) anaesthesia was induced by
pentobarbital sodium (20 mg kg–1, Nembutal, Sanofi, Libourne
Cedex, France) and maintained by halothane (0.8–1.0 %,
Fluothane, Zeneca, Planckstadt, Germany) and N2O
(0.5 l min–1). Depth of anaesthesia was assessed by repeated
testing of the eyelid reflex. At induction of anesthesia, masseter
relaxation was also assessed. A left flank incision was made to
insert a polyurethane catheter into the abdominal aorta, a silastic
catheter into the renal vein and a flow probe (6SS, Transonic,
Ithaca, NY, USA) into the left renal artery. Eighteen dogs also
received an inflatable occluder in the same renal artery and a
second polyurethane catheter with its tip in the vessel distal to the
occluder. Catheters and cables exited the animal’s neck.
Prophylactic antibiotics were given (Tardomycel, Bayer; 3 ml s.c.
on days 0, 3 and 6 post surgery) and at least 10 days were allowed
for recovery after surgery before experimentation started.
Catheters were flushed and refilled with heparinised saline
(1700 i.u. ml_1) every second or third day.
Measurements
All experiments were carried out between 07.30 and 11.30 h on
dogs that were trained to rest on their right flank. Arterial pressure
in the aorta (AP) and RAP were measured from the arterial
catheters (Statham P23XL with Gould Pressure Processor). RBF
was obtained by an external flow meter (Transonic T106 or T108)
with its low pass filter set to 10 Hz. No filter was applied for AP and
RAP measurements. In 8 experiments, the air pressure used to
control the vascular occluder was also measured by a pressure
transducer (Model BTE 4005G0, Sensor-Technics). All data were
recorded at 20 Hz on a computer.
Protocols
To investigate autoregulation of RBF both in the time and
frequency domain, two methods were employed: (1) analysis of
the time course of the adaptive changes in renal vascular resistance
(RVR) in response to a rapid increase in perfusion pressure (step
response) and (2) calculation of the transfer function between the
spontaneous fluctuations in RAP and RBF. Both types of
experiment were performed under different experimental
conditions, as explained below. Each experiment was conducted
on a different day in individual dogs. The order of the experiments
was assigned randomly to each individual dog. After
administration of an angiotensin converting enzyme (ACE)
inhibitor (see ‘Experimental conditions’ below), at least one
additional day of recovery was allowed. Not every protocol was
performed in every individual, but a control experiment was
carried out in every dog.
Step response
RAP was reduced to 50 mmHg for 60 s and was then restored
rapidly to systemic AP. The reduction in RAP was achieved by
graded inflation of the implanted occluder by hand. This
procedure is referred to as ‘pressure reduction’ hereafter. Under
each experimental condition, at least three successive pressure
reductions were made at 10 min intervals. At the end of each
experiment, the renal artery was completely occluded for 30 s to
obtain the zero flow offset. For more details, see Just et al. (2001).
Experimental conditions
Control (n = 16). After a resting period of 10 min, three pressure
reductions were made at intervals of 10 min, i.e. 10, 20 and 30 min
after the start of the experiment. In four dogs, three further
pressure reductions were made at 70, 80 and 90 min after the start
of the experiment to check the stability of the results over time.
Fourteen of these experiments were identical to those used in the
control group in a previous study (Just et al. 2001).
ACE inhibition (n = 8). To inhibit endogenous ANGII
production, dogs received an oral dose of ramipril (Hoechst
Marion Roussel, Frankfurt, Germany; 2 mg kg–1 in 20 ml saline)
1 h before the start of control experiments. Experiments
commenced with a resting period of 10 min, so that pressure
reductions were made 70, 80 and 90 min after ramipril
administration and at similar times of the day as in controls.
ACE inhibition + ANGII (n = 8). To elevate the plasma levels of
ANGII above the resting level in the absence of endogenous
modulations, the dogs received a constant infusion of ANGII
(5 ng kg_1 min_1 in 12 ml saline ..), which commenced 40 min
after ramipril administration (2 mg kg–1). This dose of ANGII was
used because it has been shown by others to elevate plasma ANGII
in dogs to a range that is similar to that observed after moderate
physiological stimulation by sodium restriction (Olsen et al.
1985). The experiment started 20 min after the start of the ANGII
infusion with a resting period of 10 min, so that pressure
reductions were made 70, 80 and 90 min after ramipril
administration and 30, 40 and 50 min after the start of the ANGII
infusion, and at similar times of the day as in the controls. In four
dogs, three further pressure reductions were made 70, 80 and
90 min after the start of the experiment (i.e. 90, 100 and 110 min
after starting ANGII treatment) to detect potential delayed effects
of ANGII.
Transfer function
AP and RBF were recorded continuously for 225 min.
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Experimental conditions
Control (n = 13). The recording was made under the same
control conditions as those described above. Eight of these
experiments were identical to those used in previous studies (Just
et al. 1998b, 1999).
ACE inhihibition (n = 6). As in the step response experiments,
ramipril (2 mg kg–1) was given orally 60 min before the start of
recording. To ensure that ACE was inhibited sufficiently for the
entire 4 h recording period, an additional dose of 1 mg kg–1 was
given 10 min before the start of recording. This regimen has been
shown previously to eliminate the pressor effect in response to
prolonged reduction in RAP for at least 2 h (Just et al. 1998a).
ACE inhibition + ANGII (n = 7). An oral dose of ramipril was
given 60 min (2 mg kg–1) and 10 min (1 mg kg–1) before the start
of recording. A continuous infusion of ANGII (5 ng kg_1 min_1 in
12 ml saline i.v.) was started 20 min before the start of recording.
Data analysis
Step response
The original 20 Hz RBF and RAP data from the step responses
were smoothed with a sliding average over 40 values (2 s). RVR
was calculated from these data by dividing [RAP _ RAP0] by
[RBF _ RBF0], where RAP0 is the pressure at which RBF ceases
and RBF0 is the zero flow offset. RAP0 was assumed to be
16 mmHg in all cases, based on the observed value at the end of the
step response experiments in the present and a previous study
(Just et al. 2001). The exact time points of the beginning and end
of the RAP reductions were either determined by visual inspection
of the original 20 Hz RBF data or were automatically determined
from the air pressure in the occluder, if available. Based on these
time points, mean curves were calculated for all responses in an
experiment and then averaged over all dogs in a group. In
addition, the following features of the time course of RVR were
determined automatically. Baseline (BASE): mean obtained from
the last 60 s prior to the pressure reduction. Minimum resistance
(MIN): mean obtained from the initial 2.5 s after pressure release.
First maximum: maximum value found between 2.5 and 10 s after
pressure release after smoothing with a secondary sliding average
over 40 of the primary smoothed values mentioned above. Plateau
(PLAT): mean obtained between 10 and 25 s after release. Second
maximum: maximum found between 25 and 80 s after release
after further smoothing by a secondary sliding average over 40 of
the primary smoothed values.
To estimate the relative contribution of the first and the second
rise of RVR to the total autoregulatory response, the rise of RVR
from MIN to PLAT was expressed as a percentage of the total
response between MIN and BASE (PLAT% = [PLAT _ MIN]/
[BASE _ MIN] w 100). The same normalisation to the total
response was applied to all RVR values of the time courses of each
individual pressure reduction (Fig. 1). HR was determined offline,
beat by beat, from the 20 Hz AP signal.
Transfer function
The 20 Hz data files from the 4 h recordings were digitally low pass
filtered (3.5 Hz cut-off, finite-impulse-response, order 50) and
then reduced 4-fold to a rate of 5 Hz. These 5 Hz data were split
into eight blocks of 8192 data points (~27 min) each. The transfer
spectrum was calculated from [AP _ RAP0] and [RBF _ RBF0]
(each normalized to the respective mean value) by the Blackman-
Tukey algorithm. A zero offset of 0 ml min_1 was assumed in 4
dogs in which no vascular occluder had been implanted. After
conversion of the gain values into decibels (20log[gain]), a mean
spectrum was calculated from the consecutive spectra and
averaged for all dogs in a group. Power density spectra of AP were
calculated from the same data blocks. Integrated spectral density
(iPSD) was derived by adding the spectral densities and
multiplying by the size of the frequency range. For all spectra, the
DC component and the lowest two frequencies were discarded so
that the lowest frequency assessed was 0.0018 Hz.
Statistical analysis
Data from all groups were analysed in a one-way ANOVA for
repeated measures, followed by Student-Newman-Keuls post hoc
test, using Sigmastat 2.03 (SPSS Inc., Chicago, IL, USA).
Normality was tested with the Kolmogorov-Smirnov test and
equality of variances was assessed with the Levene-Median test. If
data for groups were not normally distributed or had unequal
variances, a Kruskal-Wallis one-way ANOVA on ranks was used,
followed by Dunn’s post hoc test. In all cases, a P value of < 0.05 was




Control. The time course of RVR before and after a step
reduction in RAP under control conditions is depicted
in Fig. 1 for the pooled data of all 16 step response
experiments. The 60 s period of RAP reduction is not
shown. Accordingly, negative values on the x-axis refer to
the time immediately before the RAP reduction, whereas
positive values denote the time after release from the
reduction step. RVR fell to ~50 % of the baseline level
during the period of RAP reduction. This reflects the
maximum vasodilator capacity achieved by means of RBF
autoregulation. From this value, RVR returned to baseline
with a characteristic time course. Specifically, within the
first 10 s after the end of RAP reduction, RVR rose rapidly
to ~70 % of baseline, a change equivalent to 40 % of the
total RVR response to RAP reduction, i.e. from baseline
RVR to the lowest value immediately after the pressure
step. This will be referred to as the first response.
Thereafter, RVR increased at a slower rate, which will be
called the plateau. At 20–30 s after the pressure step, RVR
started to rise rapidly again and, after overshooting to
119 ± 3 % of the baseline level at 39 ± 2 s, it returned to
100 % of the baseline level. This reaction will be referred to
as the second response. In Fig. 2A, the time course of RVR
is normalised to the total change between the baseline level
(100 %) and the lowest level after release of the RAP
reduction (0 %). We have shown previously that the
second response is eliminated completely by furosemide
(frusemide) (Just et al. 2001) and, therefore, provides
information about the function of TGF. Since the first
response probably reflects the myogenic response, and
both responses impinge on the plateau, the level of the
plateau provides an estimate of the relative contribution of
TGF and the myogenic response to the overall auto-
regulation of RVR.
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ACE inhibition. After inhibition by ramipril of
endogenous ANGII production, mean RBF was elevated
slightly (Table 1), mean RAP was reduced (Table 1) and
baseline RVR was decreased (Table 2), although none of
these changes was statistically significant. HR was not
altered (Table 1). The minimum RVR immediately after
release from the RAP reduction (that is, the level of RVR
independent of autoregulation) was also unaltered
(Table 2). The influence of ACE inhibition on the time
course of RVR after release from the RAP reduction is
depicted in Fig. 2B. While the general temporal pattern
was not affected, the overshoot of the second response was
entirely prevented (Table 2). However, the level of the
plateau was not altered (Fig. 2B, Table 2).
ACE inhibition + ANGII. After elevation of ANGII levels
above the control by infusion of ANGII after ramipril,
mean RAP was elevated while HR remained unchanged
(Table 1). The same was true in comparison to data for
ACE inhibition alone. The slight reduction in RBF did not
reach statistical significance (Table 1), but due to the
increase in RAP, baseline RVR was almost twice as high as
during control or during ACE inhibition alone (Table 2).
Nevertheless, the minimum RVR immediately after
release from the RAP reduction was not different from the
control nor from data for ACE inhibition alone. The time
course of RVR after release from the RAP reduction also
remained virtually unchanged after ACE
inhibition + ANGII (Fig. 2C, Table 2). The relative level of
the plateau was not altered from the control (Fig. 2C,
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Figure 1. Step response of renal vascular resistance
(RVR) after sudden release from a reduction of
renal artery pressure
Averaged time course of RVR before and after reduction of
renal artery pressure to 50 mmHg for 60 s. The period of
pressure reduction is not shown. Time = 0 s corresponds to
the time of release from the pressure reduction.
Mean (continuous trace) ± ... (dotted traces) from
pooled data of all 16 control experiments.
Table 1. Baseline haemodynamic data
Step response experiments Transfer function experiments
————————————————— —————————————————
Experimental condition n RAP HR RBF n RAP HR RBF 
(mmHg) (beats min_1) (ml min_1) (mmHg) (beats min_1) (ml min_1)
Control 8 97 ± 3 75 ± 3 244 ± 23 6 100 ± 5 74 ± 4 192 ± 24
ACE inhibition 8 92 ± 3 77 ± 5 309 ± 23 6 91 ± 5 80 ± 6 231 ± 21
Control 8 91 ± 4 74 ± 7 281 ± 28 7 97 ± 3 66 ± 2 255 ± 33
ACE inhibition + ANGII 8 109 ± 5*† 75 ± 5 218 ± 29 7 113 ± 3*† 70 ± 4 185 ± 20
RAP, mean renal artery pressure. HR, mean heart rate. RBF, mean renal blood flow. RAP and RBF for the
step response were derived from the last 60 s before each pressure reduction, while all other values were
averaged over the entire recording period. Data are mean ± ... n, number of animals. *P < 0.05 vs. paired
control. † P < 0.05 vs. ACE inhibition alone.
Table 2. Characteristics of the step response of renal vascular resistance
Maximum Maximum 
Experimental condition n Baseline Minimum Plateau of 1st response of 2nd response
(mmHg ml_1 min) (mmHg ml_1 min) (% of response) (% of plateau) (% of baseline)
Control 8 0.38 ± 0.04 0.19 ± 0.02 35 ± 2 93 ± 3 119 ± 6
ACE inhibition 8 0.27 ± 0.02 0.17 ± 0.01 31 ± 4 91 ± 2 103 ± 2*
Control 8 0.29 ± 0.03 0.15 ± 0.02 45 ± 2 98 ± 2 120 ± 5
ACE inhibition + ANGII 8 0.48 ± 0.04*† 0.16 ± 0.02 51 ± 4† 105 ± 3† 139 ± 17
Baseline refers to renal vascular resistance (RVR) before the pressure reduction. Minimum refers to RVR
immediately after pressure release. Plateau refers to RVR during the plateau expressed as a percentage of the
total response between baseline and minimum. Maximum of the first response refers to the maximum RVR
detected 2.5–10 s after release of the RAP reduction, expressed as a percentage of the level of the plateau.
Maximum of the second response refers to the maximum RVR detected 25–80 s after pressure release,
expressed as a percentage of baseline. Data are mean ± ... n, number of animals. *P < 0.05 vs. paired
control. † P < 0.05 vs. ACE inhibition alone.
Table 2). The same results were obtained in four dogs, in
which the step responses were repeated at 90–110 min
after the start of ANGII (data not shown). In these
experiments, the plateau was at 54 ± 7 % of the total
response, which was nearly identical to the value obtained
in control experiments at a corresponding time after the
start of the experiment (53 ± 4 %). Minimum RVR after
release (0.14 ± 0.02 mmHg ml_1 min), and the degree of
overshoot for the first (103 ± 3 % of plateau) and the
second response (109 ± 4 % of baseline) during prolonged
ANGII infusion were also not different from the respective
control experiments (0.13 ± 0.01 mmHg ml_1 min,
104 ± 5 % and 120 ± 9 %). 
Although the relative level of the plateau was significantly
higher than in traces for ACE inhibition alone (Table 2), it
should be noted that these experiments were not made in
the same animals and a slight difference was already
present between the controls of the two groups (Table 2).
Transfer function
Control. The transfer spectra between the spontaneous
fluctuations of RBF and RAP (Fig. 3A) show the same
pattern as previously described in several studies on rats
and dogs (Daniels et al. 1990; Holstein-Rathlou et al. 1991;
Cupples et al. 1996; Just et al. 1998b) In the frequency
range below 0.01 Hz, i.e. for slow changes in RAP, the gain
displayed low values, indicating the presence of active
autoregulation. At frequencies above 0.2 Hz, high gain
values were observed, indicative of weak or absent
autoregulation. The intermediate frequency range was
characterised by two corner frequencies located around
0.03 Hz and 0.1 Hz, respectively. The lower corner
frequency has been shown in previous studies (Daniels et
al. 1990; Ajikobi et al. 1996; Cupples & Loutzenhiser, 1998;
Just et al. 1998b) to reflect the action of TGF, while the
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Figure 2. Normalized step response of RVR in response to
normal, reduced and elevated levels of angiotensin II
(ANGII)
Averaged time course of RVR after release from a reduction of
renal artery pressure to 50 mmHg for 60 s. Time = 0 s corresponds
to the time of release from the pressure reduction. Values are
normalized to the total RVR response between the baseline level
before the pressure reduction (100 %) and the minimum level
immediately after release (0 %). Mean (continuous traces) ± ...
(dotted traces). A, pooled control response from all 16 control
experiments. B, response during control conditions (thin line) and
after inhibition of endogenous ANGII formation by ramipril (thick
line) in 8 dogs. C, response during control conditions (thin line)
and during elevation of plasma ANGII above the resting level by
chronic ANGII infusion (5 ng kg_1 min_1) after ramipril treatment
(thick line) in 8 dogs.
Figure 3. Transfer function between renal blood flow
(RBF) and arterial pressure (RAP) in response to normal,
reduced and elevated levels of ANGII
Averaged spectra of the gain of the transfer function between the
spontaneous fluctuations of RBF and RAP in resting conscious
dogs over 4 h. Gain values are expressed in decibels. Mean
(continuous lines) ± s.e.m. (dotted lines). A, pooled baseline
spectrum of all 13 control experiments. B, spectra during control
conditions (thin line) and after inhibition of endogenous ANGII
formation by ramipril (thick line) in 6 dogs. C, spectra during
control conditions (thin line) and after elevation of plasma ANGII
levels above the resting level by chronic ANGII infusion
(5 ng kg_1 min_1) after ramipril treatment (thick line) in 7 dogs.
higher corner frequency is generally believed to be associated
with the function of the myogenic response (Holstein-
Rathlou et al. 1991; Cupples et al. 1996; Just et al. 1998b).
ACE inhibition. After ramipril, mean RAP was slightly
reduced, and mean RBF elevated, while HR remained
unchanged (Table 1). In the transfer spectrum, the gain
below 0.01 Hz was not altered after ramipril (Fig. 3B,
Table 3) indicating maintained autoregulatory efficiency.
The lower corner frequency was detected at
0.025 ± 0.001 Hz under control conditions, which was not
significantly different from the value after ramipril
(0.026 ± 0.001 Hz). The average gain between 0.015 and
0.035 Hz showed a trend for a slight reduction (Fig. 3B,
Table 3), which would indicate a diminished resonance of
TGF. The higher corner frequency was detected at
0.12 ± 0.02 Hz under control conditions, which was not
significantly different after ramipril (0.14 ± 0.01 Hz), and
its gain was at most slightly reduced (Table 3). The spectral
power of the fluctuations of AP, which represents the
driving force for the transfer function, was not
significantly different from the control in any of the three
frequency ranges investigated.
ACE inhibition + ANGII. After elevation of the ANGII
plasma levels during ACE inhibition the average gain
below 0.01 Hz was not altered compared to the control
condition. The lower corner frequency (0.019 ±
0.001 Hz) was also not different from the control
(0.021 ± 0.001 Hz). The average gain in this frequency
range was slightly but not significantly elevated as
compared to the control (Fig. 2C, Table 3). The same was
true in comparison to ACE inhibition alone (Table 3). The
spectral power of the fluctuations of AP was not
significantly altered in this frequency range
(8.3 ± 0.8 mmHg) compared to the controls
(6.1 ± 0.7 mmHg). The higher corner frequency was
located at 0.14 ± 0.01 Hz, which did not differ from the
control condition and or from ACE inhibition alone.
However, the gain between 0.06 and 0.20 Hz was markedly
enhanced compared to control as well as to ACE inhibition
alone (Fig. 2C, Table 3), indicating augmented oscillations
of the myogenic response. In contrast, the spectral power
of the underlying fluctuations of AP in this frequency
range was not elevated (21 ± 6 vs. 17 ± 6 mmHg). There
was also an elevation of the gain at higher frequencies. This
frequency range is currently believed to reflect pressure
passive properties of the vasculature (Holstein-Rathlou &
Marsh, 1994). Accordingly, the elevated gain may indicate
a modulation of the compliance or of the level of pulse
wave reflections in this vascular bed.
DISCUSSION
The present results show that despite substantial changes
in the mean level of RBF and RVR, the overall
autoregulation of RBF is not affected by alterations in
ANGII plasma concentrations within the physiological
range. The elevation of resting RVR in the face of
unchanged minimum RVR after a reduction in renal
perfusion pressure indicates that ANGII enhances overall
autoregulatory vasoconstriction. However, the
susceptibility of the myogenic response and TGF to
feedback oscillations (represented by the overshoot of the
first and second responses and the gain at the higher and
lower corner frequencies) varied slightly with the level of
plasma ANGII in the direction expected from
micropuncture studies, but this effect was surprisingly
small in the case of TGF. Finally, the normalised level of
RVR during the plateau phase of the step response was not
altered appreciably by the experimental interventions,
suggesting that the relative contribution of the myogenic
response and TGF (or any other possible mechanisms) to
this autoregulatory response is not modulated
physiologically by circulating ANGII. In conjunction with
the augmentation of the overall autoregulation, this
implies that ANGII enhances not only TGF, but also the
myogenic response.
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Table 3. Characteristics of the transfer function between renal blood flow and renal
artery pressure
Lower Higher
Experimental condition n < 0.01 Hz corner frequency corner frequency
(dB) (dB) (dB)
Control 6 _6.5 ± 1.0 0.3 ± 0.6 2.5 ± 0.5
ACE inhibition 6 _5.7 ± 0.7 _1.6 ± 0.7 0.8 ± 0.4
Control 7 _7.5 ± 1.0 _1.2 ± 0.5 2.3 ± 0.6
ACE inhibition + ANGII 7 _5.7 ± 1.4 0.6 ± 0.6 6.2 ± 0.5*†
Gain values of the transfer function were averaged over the following frequency ranges. < 0.01 Hz (overall
autoregulatory efficiency): 0.0018 – 0.01 Hz. Lower corner frequency (TGF): 0.015–0.035 Hz. Higher corner
frequency (myogenic response): 0.06–0.20 Hz. Data are mean ± ... n, number of animals. * P < 0.05 vs.
paired control. † P < 0.05 vs. ACE inhibition alone.
Autoregulatory efficiency
During the pressure reductions, RAP was reduced to
50 mmHg (which is below the lower limit of RBF
autoregulation (~65 mmHg) under our experimental
conditions; Kirchheim et al. 1987) to allow for complete
autoregulatory vasodilatation. Previous studies have
shown that the minimum RVR value after the pressure
reduction was the same irrespective of whether the
reduction period was prolonged for up to 5 min or
replaced by a period of complete occlusion (Just et al.
2001). Therefore, the RVR values recorded in the present
study probably give a reliable estimate of the smallest RVR
that can be achieved by means of the autoregulatory
response. Our results showed no significant change in the
RVR in response to variations in plasma ANGII levels
within a physiological range. Even if there is a slight trend
for elevated RVR at higher levels of ANGII, this effect is
very small in comparison to the influence on baseline RVR
and to the large range of vasodilatation available for the
autoregulatory response.
The efficiency of autoregulation was estimated from the
gain of the transfer function between AP and RBF in the
frequency range below 0.01 Hz. Kinetic studies of the
response times of the myogenic response (Clausen et al.
1992) and tubuloglomerular feedback (Daniels &
Arendshorst, 1990), as well as the location of corner
frequencies in the transfer spectrum (Holstein-Rathlou &
Marsh, 1994), indicate that autoregulation is fast enough
to exert its full effect in this frequency range. A previous
study demonstrated that only part of this regulatory
capacity is used under physiological conditions (Just et al.
1998b). Therefore, the gain of the transfer function in the
frequency range of 0.0018–0.01 Hz directly reflects the
dynamic autoregulatory efficiency, which is active under
these conditions in a time range of 2–10 min. This measure
was not affected significantly by either experimental
intervention. Therefore, neither at the mean level nor
during endogenous fluctuations in plasma levels does
ANGII appear to affect autoregulatory efficiency under
normal conditions. Our data demonstrate that, as for the
static response (Abe et al. 1976; Arendshorst & Finn, 1977;
Hall et al. 1977; Persson et al. 1988) short-term dynamic
autoregulation of RBF is not affected by circulating ANGII
under physiological conditions. It should be noted that
this finding does not contradict the important modulatory
influence of ANGII on the regulation of RBF in the longer
term, which becomes active over a time frame of several
minutes (Cupples, 1993; Sorensen et al. 2000).
Magnitude of TGF
TGF was assessed from the second RVR response to RAP
reduction and the lower corner frequency in the transfer
function. The rationale for associating these two features
with TGF is based on previous studies in which both the
second response (Just et al. 2001) and the lower corner
frequency were completely abolished after ureteral
occlusion (Daniels et al. 1990), furosemide administration
(Ajikobi et al. 1996; Just et al. 1998b) and in the
hydronephrotic kidney (Cupples & Loutzenhiser, 1998).
Furthermore, the fluctuations in RBF at the lower corner
frequency have been found to be accompanied by parallel
changes in the velocity of tubular flow and the
concentration of chloride in the distal tubular fluid
(Holstein-Rathlou & Marsh, 1989). The close
correspondence between the response time of the second
response (36 s) and the lower corner frequency (0.025 Hz)
also suggest that both features are reflecting the same
phenomenon.
The trends for enhancement of the overshoot of the
second response and the gain of the lower corner
frequency at elevated plasma levels of ANGII are
compatible with an augmentation of TGF by ANGII.
However, this effect was remarkably small (if present at
all). When TGF is inhibited directly by furosemide
(Ajikobi et al. 1996; Just et al. 1998b) or in the
hydronephrotic kidney (Cupples & Loutzenhiser, 1998),
the gain in the lower corner frequency range does fall
markedly to levels as low as _5 dB.
The small effect of ANGII on the overshoot of the second
response and the gain of the lower corner frequency might
seem surprising in view of its strong influence on TGF,
which is known from micropuncture studies. Such studies
have demonstrated an attenuation of TGF after inhibition
of ACE (Ploth et al. 1979; Stowe et al. 1979; Schnermann et
al. 1984; Mitchell & Navar, 1988), ANGII receptor
blockade (Stowe et al. 1979; Ploth & Roy, 1982; Mitchell &
Navar, 1988; Welch & Wilcox, 1990; Braam & Koomans,
1995) and in AT1 receptor knockout mice (Traynor &
Schnermann, 1999) Conversely, enhanced sensitivity has
been found after ANGII infusion (Huang & Navar, 1988;
Mitchell & Navar, 1988; Schnermann & Briggs, 1989b;
Braam & Koomans, 1995). Similar ANGII-dependent
modifications in TGF gain also seem to play a role during
physiological adaptations, such as volume expansion
(Schnermann & Briggs, 1990). However, the degree of
overshoot of a control system (derived in the present study
from the second response and the corner frequency) does
not depend only on the magnitude of the contribution of
the underlying mechanism, but also on the impact of
damping factors. Accordingly, possible explanations for
these observations would either be a generally small effect
of ANGII on the strength of TGF, or a considerable
augmentation by ANGII of the strength of TGF, which is
balanced by a parallel enhancement of damping factors. In
view of the strong evidence for a modulatory effect of
ANGII on TGF, mentioned above, as well as on the
overall augmentation of autoregulatory vasoconstriction,
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indicated by the elevation of resting RVR during unaltered
minimum RVR, the latter explanation is more likely.
Magnitude of the myogenic response
The gain at the higher corner frequency after ANGII
infusion was enhanced markedly, despite the fact that
fluctuations in AP were largely unaltered. This finding
indicates an enhanced susceptibility to resonance of the
myogenic response induced by ANGII. However, as
explained above for TGF, these data do not allow us to
decide whether this effect is is due to an enhancement of the
absolute strength of the myogenic response or a reduction
of damping factors. Nevertheless, the marked gain at the
higher corner frequency suggests that some augmentation
of the absolute strength might be involved.
Balance between myogenic response, TGF and a
further possible  mechanism
The relative contribution of the myogenic response, TGF
and (possibly) an additional slower mechanism (Just et al.
2001) to autoregulation of RBF and, thus, to basal vascular
tone under resting conditions was estimated from the level
of RVR during the plateau phase of the step response. This
was based on the following consideration. During the
period in which RAP is reduced below the lower limit of
autoregulation, all mechanisms will change to produce
their maximum vasodilator signal. After release of the
occlusion, all mechanisms will return to baseline levels
that are appropriate for the resting level of RAP, but the
myogenic response will do so more quickly than the other
two. Therefore, at the time of the plateau, the myogenic
response will already have adapted to the increase in RAP,
while both TGF and the slower mechanism will continue
to provide the maximum vasodilator signal appropriate
for a RAP of 50 mmHg. Accordingly, if the contribution of
the myogenic response is enhanced relative to TGF and the
slower mechanism, it will raise the plateau to a higher level.
Conversely, if the contribution of TGF and the slower
mechanism gained more influence, the RVR would
remain at a reduced level during the plateau phase.
Consistent with this hypothesis, in a previous study the
level of the plateau was found to increase markedly after
direct inhibition of TGF by furosemide (Just et al. 2001).
Therefore, to facilitate the estimation of the relative
contribution of the myogenic response to autoregulation
of RBF, the time courses of the RVR shown in Fig. 1 were
normalised to the total response of RVR to RAP reduction,
i.e. from baseline RVR to the minimum RVR after
pressure reduction. The normalised level of RVR during
the plateau was remarkably stable during the experimental
modulations of plasma ANGII. Even prolonged exposure
to elevated levels of ANGII for more than 1 h did not alter
the relative position of the plateau. This indicates that the
relative contribution of the myogenic response (and,
therefore, the balance to the two other mechanisms) is
maintained under these conditions, despite the variation
in baseline RVR. It is more difficult to derive an estimate of
the relative contribution of TGF to autoregulation of RBF,
because the plateau is also affected by an additional
mechanism, which is derived from either a slow
component of the myogenic response, a different
regulatory mechanism or capacitative effects (Just et al.
2001). Whatever the nature of the additional mechanism,
under the assumption that this mechanism is either not
altered by ANGII or changed to the same extent as the fast
component of the myogenic response, it is safe to conclude
that the balance of all three mechanisms is not substantially
altered in response to different plasma levels of ANGII.
A crucial factor when considering the aforementioned
hypothesis is that the myogenic response should be
separated sufficiently in time from the other two
mechanisms. This seems justified with regard to the
constrictor response to a step reduction in perirenal
pressure, which was found to have a half-time of 1.16 s and
was complete after 2.5 s (Clausen et al. 1992). Similarly, in
the juxtamedullary nephron preparation, after non-
pharmacological elimination of TGF by papillectomy, the
constrictor response of afferent arterioles to a pressure step
in the renal artery was complete after 6.3 ± 0.9 s (Walker et
al. 2000). In isolated afferent arterioles, the constrictor
response to a pressure step reached its maximum after 10 s
(Juncos et al. 1995). A slower response time was reported
for isolated afferent arterioles by Yip & Marsh (1996), but
these authors considered in their discussion that the
responses were slower than would be expected from
observations in vivo, possibly due to accumulation of nitric
oxide. Slower response times of 20–60 s were observed in
the juxtamedullary nephron preparation (Carmines et al.
1990; Casellas & Moore, 1993), but in these experiments,
TGF was intact, so that the maximum response might have
been due to TGF. By contrast, the TGF response to step
changes in the tubular perfusion rate comprises an initial
delay of 18 s and can take up to 60 s to complete in the rat
(Daniels & Arendshorst, 1990; Holstein-Rathlou & Marsh,
1994). Because the TGF response time is largely governed
by the length of Henle’s loops, these responses are
expected to be even slower in the dog. The additional
regulatory mechanism that might exist may start
immediately, but has a very slow, steady time course of at
least 60 s for completion, so that during the time of the
plateau it will have restored production of the
vasoconstrictor signal by only a negligible degree (Just et
al. 2001).
Another concern is that the mechanisms might not be
purely additive. The myogenic response and TGF are
known to comprise intricate interactions (Schnermann &
Briggs, 1989a; Chon et al. 1994; Walker et al. 2000).
However, if these interactions are positive (i.e.
constriction in one signal induces constriction in the
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other) and occur at the same time as the direct effect of
each mechanism independently, the above hypothesis
regarding the level of the plateau will remain valid. To our
knowledge, a positive interaction has never been
questioned and the temporal congruence of direct
response and interaction seems reasonable. By contrast, it
is less probable that TGF sends a constrictor signal to the
myogenic response at the same time as it produces a
vasodilator signal on its own. This does not exclude the
possibility that the observed stability of the balance
between the mechanisms might be due to such inter-
actions. In fact, this is an appealing explanation.
With the elevation of plasma ANGII in the present study,
the mean level of resting RVR rose considerably, while the
minimum level of RVR at the end of the pressure
reduction step was not significantly affected, indicating
that the overall effect of autoregulation-induced
vasoconstriction was enhanced. Accordingly, the
maintained relative contribution of the myogenic
response discussed above implies that, as well as its well-
known effect on TGF, ANGII also augmented the strength
of the myogenic response, or at least its fast component.
Such an augmentation of myogenic vasoconstriction has
indeed been described previously for renal microvessels of
the hydronephrotic kidney (Kirton & Loutzenhiser, 1998).
Although we are not aware of other studies demonstrating
such an effect in the renal circulation, enhancement of the
myogenic response by ANGII (de Wit et al. 1998) or
dietary sodium restriction (Nurkiewicz & Boegehold,
2000) and attenuation of the myogenic response by ACE
inhibition (Savage et al. 1999) or AT1-receptor blockade
(Nurkiewicz & Boegehold, 2000) have been observed in
skeletal muscle microvessels and femoral arteries. We can
only speculate about possible intracellular mechanisms
that might mediate such an interaction. Possible
mechanisms include an enhanced membrane
depolarisation or transmembrane influx of Ca2+, altered
local distribution of cytoplasmic Ca2+ and an effect on the
cascade of calmodulin and myosin light chain
phosphorylation or on rho-kinase and Ca2+ sensitivity
(Somlyo, 1997; Schubert & Mulvany, 1999).
Limitations
There is a possibility that during the 60 s period of RAP
reduction, intrarenal production of ANGII might have
affected the RBF response to the subsequent pressure step.
Direct comparison of the two experimental groups, which
received the ACE inhibitor with or without concomitant
ANGII infusion (although not in the same individuals)
would be compatible with this view. However, the higher
plateau level in the group infused with ANGII (Table 2)
suggests that the myogenic response was even more
enhanced than TGF and the additional regulatory
mechanism(s).
It should be mentioned that ANGII infusion elevated RAP
slightly, while the steps were always done from 50 mmHg
to determine minimum RVR. In addition, ANGII is
known to shift the lower limit of RBF autoregulation to
lower pressures (Kirton & Loutzenhiser, 1998; Sorensen et
al. 2000). Therefore, the pressure perturbation might not
have been exactly comparable under all conditions.
However, if such differences in the perturbation did
indeed affect the results, the observed stability of the level
of the plateau implies that their influence was exactly
compensating for any underlying change.
Conclusions
Taken together, the results of the present study
demonstrate that a physiological range of ANGII plasma
levels does not affect the efficiency of autoregulation of
renal perfusion during resting conditions and only very
slightly alters the autoregulation-independent component
of RVR. In addition to its well known effect on TGF,
ANGII also enhances the sensitivity of the myogenic
response, so that the relative contribution of the myogenic
response to overall autoregulation remains unaltered.
Accordingly, the relative contribution of the myogenic
response, TGF and a possible further mechanism to
autoregulation and resting vascular tone in the kidney is
most probably also maintained during exposure to
different levels of ANGII.
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